Improved treatment and a better life for people with psychiatric and neurological disorders.
More than 700 million people are affected by psychiatric and neurological disorders worldwide – this is equal to 13% of the global disease burden.1 Progress in Mind is Lundbeck’s dedication to addressing the global burden of psychiatric and neurological disorders.
Our foundation for progress
Brain disease is a global health problem.2 Through improved medical treatments and continuous focus on the unmet needs of patients, we want to address the issue and call for greater awareness of the massive economic and societal burden psychiatric and neurological disorders represent.
With our unique position as a specialist in psychiatric and neurological disorders, we want to raise disease awareness and challenge the international agenda for broader acceptance of patients and increased opportunities for better treatment.
Why do more than 700 million people in the world have to live with psychiatric and neurological disorders?3
Why do almost 50% of people with psychiatric and neurological disorders not receive any treatment?4
Why should people with psychiatric and neurological disorders live 10-20 years less than others?5
Why do more than 70% of people living with psychiatric and neurological disorders experience discrimination?6
Why is it that 90% of all suicide victims suffered from a psychiatric and neurological disorders?7
Global progress for people living with psychiatric and neurological disorders requires a multifaceted approach. First and foremost, we continue to develop new and improved medical treatments and continue to focus on the patient, ensuring that he or she regains possibilities. But we also work to embrace our vision from two other essential dimensions: We encourage increased support to affected families and we engage in communities to create broader social acceptance of patients.
To raise awareness and prevent stigmatization, we use our voice as specialists in psychiatric and neurological disorders and share our knowledge about the many unmet needs in the treatment of psychiatric and neurological disorders. We reach into both professional and patient communities to offer disease education and support programmes to healthcare professionals, patients and their families. Our global presence enables us to let successful, local initiatives travel the world and make a difference to patients everywhere.
- http://www.ifpma.org/wp-content/uploads/2016/01/2012_IFPMA_Position_Paper_on_MNDs.pdf, http://www.who.int/mediacentre/factsheets/fs396/en/, http://www.who.int/features/qa/55/en/index.html
- WHO Quality Rights Project – addressing a hidden emergency, 2011
- http://www.who.int/mediacentre/factsheets/fs396/en/, http://www.who.int/features/qa/55/en/index.html, http://www.ifpma.org/wp-content/uploads/2016/01/2012_IFPMA_Position_Paper_on_MNDs.pdf
- Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Schizophr Res. 2000;45(1–2):21–8.
- http://blog.ted.com/2012/09/11/some-stats-on-the-devastating-impact-of-mental-illness-worldwide-followed-by-some-reasons-for-hope/, http://www.time-to-change.org.uk/what-are-mental-health-problems/stigma-discrimination
- https://www.nami.org/Learn-More/Mental-Health-Conditions/Related-Conditions/Suicide, http://who.int/mental_health/suicide-prevention/world_report_2014/en/, http://journals.cambridge.org/download.php?file=%2FPSM%2FPSM33_03%2FS0033291702006943a.pdf&code=6e086fc0f55440640244640216120c97